Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Lilly patents TYK2 JH2 domain ligands

July 3, 2020

CREDO 2 pivotal global phase III study of olokizumab meets endpoints

July 3, 2020

Novartis patents chondrogenesis inducers

July 1, 2020

FDA clears IND for RP-L401 gene therapy for infantile malignant osteopetrosis

June 30, 2020

Janssen discontinues phase III LOTUS study of ustekinumab in SLE

June 29, 2020

Novartis presents compounds for arthritis

June 26, 2020

Tarapeutics Science patents PI3Kdelta inhibitors

June 22, 2020

FDA approves Cosentyx for active nonradiographic axial spondyloarthritis

June 17, 2020

Ilaris approved in U.S. for active Still's disease

June 17, 2020

Netakimab demonstrates superiority to placebo in second-line psoriatic arthritis

June 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...